Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone for asymptomatic carotid plaque and stenosis
ChiCTR2100042892Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in carotid atheroma (CAS) and Carotid artery disease (CAD) comparing Idebenone with Placebo (2 arms). Primary endpoint: Carotid plaque volume. Started Sep 2020; status: recruiting.
02
Drugs
idebenone
03
Conditions
carotid atheroma (CAS)Carotid artery disease (CAD)
Beyond the preview
Go deeper on ChiCTR2100042892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042892.